MLH1 and neoplasm: Each of the three MLH1 methylated EOCRCs from the diagnostically challenging group showed MLH1 promoter hypermethylation in their tumours (β = 0.34, 0.42 and 0.67) but not in the single normal mucosa sample tested (β = 0.07).